In 2024 alone, over 676 private equity firms and related investors acquired healthcare companies or related assets. The growing influence of private equity in the healthcare industry has not gone unnoticed on either of the federal or state levels. The trend toward increased scrutiny of private equity investments in healthcare, which started gaining traction among the states in recent years (for example, both New York and California in 2023), is increasingly apparent in legislation proposed in the last few months. This article provides an overview of the current state-of-play in federal and state regulation, and offer practical suggestions for private equity investors and healthcare providers navigating deals in the current regulatory environment.
Read the full article: Check-Up and Diagnosis: The Ongoing Scrutiny of Private Equity Healthcare Investments //
Source: https://www.paulhastings.com/insights/client-alerts/check-up-and-diagnosis-the-ongoing-scrutiny-of-private-equity-healthcare-investments